|
Home | Medical-Newswire.Com:
|
(EMAILWIRE.COM, March 31, 2011 ) Boca Raton, FL --- pharmaCline is an innovative technology and pharmaceutical company that has developed a patent pending technology and game-changing product line of antimicrobial drugs. The Company has developed a new generation of antimicrobial agents that exhibit high efficacy and greatly reduce the risk of resistance forming strains. These product formulations are listed with the FDA and will soon be ready for rapid penetration within the pharmaceutical and medical products industry.
The CompanyÂ’s new Site-Specific Penetration Technology (SSPT) for effective drug delivery will revive a retired class of pharmaceuticals into newly transformed high-efficacy agents that will now therapeutically perform against the most disease-resistant strains. The management team believes that the implementation of this technology and powerful drug delivery will provide the Company with a suite of unique products that will be far superior yet competitively priced to any existing products in the marketplace. With this edge, the Company intends to become a dominant leader in the OTC and prescription antibiotic product industry.
The CompanyÂ’s technology, when combined with its unique products, will provide its end-users stronger therapeutic protection against leading bacterial strains and an increased level of efficacy against the most resistant strains of disease. Over the next three years, the Company anticipates the introduction of a minimum of seven new products designed to effectively treat wounds infected with MSRA, VRE, Group-A Strep, Acinetobacter strains, Staph saprophyticus, E. coli, Enterobacter cloacae, Klebsiella pneumonia, Proteus vulgaris, and Pseudomonas aeruginosa. The CompanyÂ’s products can be administered through a physicianÂ’s prescription or purchased as an over-the-counter (OTC) product and can be easily and cost effectively implemented across all commercial pharmaceutical markets.
JL Haber, Vice President of Programming at Multi Media Productions, added, “Through their unique technology, pharmaCline is truly addressing the needs of the medical industry. We are excited to have them as a guest on our program.”
About 21st Century Health
21st Century Health is an award winning targeted business show that is independently produced by Multi-Media Productions. The show provides its business viewers an in depth opportunity to find solutions to the industry problems from some of the top business leaders from across the world. Each exclusive segment is taped in our state of the art South Florida Studio.
Once selected, companies are able to present their story and solutions to industry problems in an exclusive way that sets their company apart from the others. With more than 6,000 companies participating on over 600 shows, 21st Century Health continues to be the premier and targeted outlet for the latest business stories.
21st Century Health airs on various national cable networks that are viewed by over 100 million viewers nationwide as well as internationally via DirecTV and Dish Network. The show can also be viewed through video on demand via http://www.21chv.com. The 21CHTV Series is also available at more than 27 prestigious college universities, including Carnegie Mellon University, Howard University, Dartmouth College and Georgetown University.
For specific market-by-market air dates and times, please e-mail Moniqueh@mmpusa.com. For more information, please visit http://www.21chtv.com.
Multi-Media Productions USA
Susan Waters
919 265 9502
swaters@mmpusa.com 
Source: EmailWire.com
|
|
|
|
